Chinese Osteoporotic Fracture Registration Network Platform

NCT05339425 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2025-02-25

No results posted yet for this study

Summary

China has gradually entered an aging society, and the incidence of osteoporotic fractures is increasing rapidly. Although the harm of osteoporotic fracture is huge, its diagnostic rate in China is still low. China still lacks a national osteoporotic fracture registration system, which has been established in many countries. The purpose of this study is to establish a Chinese osteoporotic fracture registration network platform (CORN), which will be helpful for the long-term comprehensive management of osteoporotic fracture population in China. This platform will help to establish a large prospective clinical cohort database of osteoporotic fractures and high-risk population in China.

Conditions

Interventions

OTHER

No additional intervention will be administered.

No additional intervention will be administered.

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    collaborator OTHER
  • Beijing Hospital

    collaborator OTHER_GOV
  • Tianjin First Central Hospital

    collaborator OTHER
  • Hebei Medical University Third Hospital

    collaborator OTHER
  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • Peking University Third Hospital

    collaborator OTHER
  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    collaborator OTHER
  • Ruijin Hospital

    collaborator OTHER
  • Affiliated Hospital of Nantong University

    collaborator OTHER
  • Shanghai Changzheng Hospital

    collaborator OTHER
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Second Xiangya Hospital of Central South University

    collaborator OTHER
  • Nanfang Hospital, Southern Medical University

    collaborator OTHER
  • The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine

    collaborator OTHER
  • First Affiliated Hospital of Fujian Medical University

    collaborator OTHER
  • Second Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER
  • The Seventh Affiliated Hospital of Sun Yat-sen University

    collaborator OTHER
  • Sichuan Province Orthopetic Hospital

    collaborator OTHER
  • The Second Affiliated Hospital of Chongqing Medical University

    collaborator OTHER
  • Daping Hospital, Army Medical Center of PLA

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • Second Affiliated Hospital of Soochow University

    collaborator OTHER
  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER
  • Peking University Shenzhen Hospital

    collaborator OTHER
  • General Hospital of Ningxia Medical University

    collaborator OTHER
  • Second Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER
  • Beijing Jishuitan Hospital

    collaborator OTHER
  • Zhejiang Hospital

    collaborator OTHER
  • Shenzhen People's Hospital

    collaborator OTHER
  • Xiangya Hospital of Central South University

    collaborator OTHER
  • Beijing Friendship Hospital

    collaborator OTHER
  • Shanghai 6th People's Hospital

    collaborator OTHER
  • Shanghai East Hospital of Tongji University

    collaborator OTHER
  • Zhongda Hospital

    collaborator OTHER
  • First Affiliated Hospital of Jinan University

    collaborator OTHER
  • Fujian Provincial Hospital

    collaborator OTHER
  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Weibo Xia, MD · Peking Union Medical College Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05339425 on ClinicalTrials.gov